State Board of Administration of Florida Retirement System’s Crescent Biopharma CBIO Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-101	Closed	-$31K	–	2400
2021 Q1	$31K	Hold	101	–	–	﹤0.01%	2362
2020 Q4	$38K	Hold	101	–	–	﹤0.01%	2342
2020 Q3	$31K	Hold	101	–	–	﹤0.01%	2309
2020 Q2	$38K	Hold	101	–	–	﹤0.01%	2305
2020 Q1	$23K	Sell	101 -2	-2%	-$764	﹤0.01%	2213
2019 Q4	$55K	Hold	103	–	–	﹤0.01%	2250
2019 Q3	$45K	Hold	103	–	–	﹤0.01%	2249
2019 Q2	$123K	Buy	+103	New	+$123K	﹤0.01%	2232

Other funds holding CBIO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Board of Administration of Florida Retirement System's CBIO Position: Q2 2021 in Review

State Board of Administration of Florida Retirement System sold out of Crescent Biopharma (CBIO) in Q2 2021, closing a stake of 101 shares — an estimated $31K sold.

State Board of Administration of Florida Retirement System first reported a position in CBIO in Q2 2019 and held it in 8 quarters. The position peaked at $123K in Q2 2019. 58 funds tracked by Wall St. Rank hold CBIO as of Q2 2021.

State Board of Administration of Florida Retirement System reported no remaining Crescent Biopharma position as of Q2 2021 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 101 Crescent Biopharma shares in Q2 2021, an estimated $31K.
State Board of Administration of Florida Retirement System first reported a position in Crescent Biopharma in Q2 2019 and held it in 8 quarters.
State Board of Administration of Florida Retirement System's Crescent Biopharma position peaked at $123K in Q2 2019.
58 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2021.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2021, filed 10 Aug 2021.